BBIOBridgeBio Pharma, Inc.

$79.37

Who owns BBIO

446 institutions reported holding BBIO for 2026Q1, together 100% of the company, more than the 422 a quarter earlier.

446

Institutions reporting a position · as of 2026Q1 · up from 422 the quarter before

Shares held by institutions
193.9M

Shares held by institutions · 100% of the company · long US equity positions only, as reported on Form 13F

Reported value
$14.9B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
36%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
28
New positions
80
Positions exited
61
Added to
169
Reduced
123
Top 10 holdersof the company
51%
Institutional ownership by quarter, 2019Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1446193.9M$14.9B
2025Q4422190.6M$14.4B
2025Q3385184.7M$9.59B
2025Q2353188.5M$8.14B
2025Q1300186.3M$6.45B
2024Q4261176.7M$4.85B
2024Q3249172.6M$4.39B
2024Q2248174.9M$4.43B
2024Q1241171.6M$5.42B
2023Q4244165.5M$6.68B
2023Q3218161.0M$4.24B
2023Q2194149.8M$2.58B
2023Q1207152.3M$2.52B
2022Q4178144.5M$1.10B
2022Q3179145.2M$1.44B
2022Q2162140.4M$1.28B
Largest reported holders, 2026Q1
HolderShares% of companyValue
VANGUARD GROUP INC17.3M8.9%$1.28B
BlackRock Inc.14.2M7.3%$1.06B
Kohlberg Kravis Roberts & Co. L.P.13.3M6.8%$985M
HENDERSON GROUP PLC13.2M6.8%$979M
VIKING GLOBAL INVESTORS LP11.8M6.1%$879M
FARALLON CAPITAL MANAGEMENT LLC9.4M4.8%$695M
Aisling Capital Management LP5.1M2.6%$378M
STATE STREET CORP4.9M2.5%$366M
GEODE CAPITAL MANAGEMENT LLC4.9M2.5%$372M
Invesco Ltd.4.6M2.4%$341M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…